If the science is there, theres not going to be much of a reason for biotechs to prolong trials if the laws allow them to release a treatment quicker... investors won't be happy with that, lol.
On one hand, I hate fat overpaid CEOs, but on the other hand I love the fact that MONEY is much more of an incentive for a cure than sympathy.
On one hand, I hate fat overpaid CEOs, but on the other hand I love the fact that MONEY is much more of an incentive for a cure than sympathy.
Comment